| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.02 |